| Followers | 22 |
| Posts | 13489 |
| Boards Moderated | 0 |
| Alias Born | 01/16/2026 |
Friday, April 03, 2026 2:00:02 AM
Gossamer Bio, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GOSS
April 3, 2026 1:50 AM
PR Newswire (US)
LOS ANGELES, April 3, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Gossamer Bio, Inc. ("Gossamer" or "the Company") (NASDAQ: GOSS) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of GOSS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.
CLASS PERIOD: June 16, 2025 to February 20, 2026
DEADLINE: June 1, 2026
CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Gossamer misled investors by concealing facts about issues with its Phase 3 PROSERA study. Based on these facts, Gossamer's public statements were false and materially misleading throughout the class period.
If you are a shareholder who suffered a loss, contact us to participate.
WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.
Join the case to recover your losses.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: David@djslawllp.com
View original content:https://www.prnewswire.com/news-releases/gossamer-bio-inc-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights--goss-302733365.html
SOURCE DJS Law Group LLP
Recent GOSS News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2026 08:01:13 PM
- GOSS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Gossamer Bio, Inc. Securities Lawsuit -- The Gross Law Firm • PR Newswire (US) • 04/07/2026 01:00:00 PM
- Gossamer Bio, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GOSS • PR Newswire (US) • 04/06/2026 09:01:00 AM
- Gossamer Bio, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – GOSS • Business Wire • 04/03/2026 11:30:00 AM
- Gossamer Bio, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GOSS • PR Newswire (US) • 04/03/2026 05:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 08:22:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 08:20:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 08:19:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 08:16:53 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/19/2026 04:15:30 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/17/2026 08:09:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/17/2026 08:04:01 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/17/2026 08:03:01 PM
- Form POSASR - Post-effective Amendment to an automatic shelf registration statement • Edgar (US Regulatory) • 03/17/2026 08:01:45 PM
- Gossamer Bio Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update • Business Wire • 03/17/2026 08:01:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/25/2026 12:21:17 AM
- Gossamer Bio Shares Plunge After Phase 3 Trial Miss • IH Market News • 02/23/2026 03:41:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 01:30:24 PM
- Gossamer Bio Announces Topline Results from the Phase 3 PROSERA Study Evaluating Seralutinib in Pulmonary Arterial Hypertension • Business Wire • 02/23/2026 01:00:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 01/28/2026 09:01:24 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 01/21/2026 05:30:29 PM
- Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 01/08/2026 10:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 09:39:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 09:38:59 PM
